SF3B1 mutations lead to the development of MDS; however, the functional consequences of SF3B1 mutations and how their deregulation of splicing leads to oncogenesis is not completely understood [30, 31]. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.